Department of Health and Human Services
National Institutes of Health
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Novel Synthetic NA Technology Development.
Date: May 9, 2022.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications. ( printed page 22541)
Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 300, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D., National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 300 Bethesda, MD 20892, (301) 594-4280 mckenneyk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS)
Dated: April 12, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.